Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000970917 | SCV001118523 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000970917 | SCV004148483 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | UNC80: BP4, BP7 |
Breakthrough Genomics, |
RCV000970917 | SCV005240950 | benign | not provided | criteria provided, single submitter | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000970917 | SCV002035681 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000970917 | SCV002037654 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004535958 | SCV004745922 | likely benign | UNC80-related disorder | 2022-11-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |